Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents
Approaches to develop effective drugs to kill cancer cells are mainly focused either on the improvement of the currently used chemotherapeutics or on the development of targeted therapies aimed at the selective destruction of cancer cells by steering specific molecules and/or enhancing the immune re...
Main Authors: | Jessica Castro, Marc Ribó, Maria Vilanova, Antoni Benito |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/1/82 |
Similar Items
-
A Nuclear-Directed Ribonuclease Variant Targets Cancer Stem Cells and Inhibits Migration and Invasion of Breast Cancer Cells
by: Jessica Castro, et al.
Published: (2021-08-01) -
Ribonucleases as potential therapeutic agents
by: Masoume Vakili-Azghandi, et al.
Published: (2021-03-01) -
Structural and Functional Differences between Homologous Bacterial Ribonucleases
by: Vera Ulyanova, et al.
Published: (2022-02-01) -
The Immunomodulatory and Antimicrobial Properties of the Vertebrate Ribonuclease A Superfamily
by: Laura Schwartz, et al.
Published: (2018-11-01) -
The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma
by: Luciano Mutti, et al.
Published: (2011-12-01)